Skip to content

Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05535465
Acronym
REACT-2
Enrollment
7500
Registered
2022-09-10
Start date
2021-12-01
Completion date
2024-09-01
Last updated
2022-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Brief summary

In the REACT 2 project, a consortium proposes to study in Burkina Faso and Côte d'Ivoire, the impact of a public health intervention in rural communities in order to improve access to malaria therapeutic and preventive arsenal for vulnerable populations (i.e. children, adolescents and pregnant women). The intervention relies on the implementation of mobile health workers to support community health workers.

Interventions

OTHERPublic health intervention

additional trained mobile health workers are hired to support and supervise the activities of community health workers

Sponsors

Institut de Recherche en Sciences de la Sante, Burkina Faso
CollaboratorOTHER_GOV
Institut Pierre Richet
CollaboratorOTHER_GOV
Expertise France
CollaboratorOTHER
Institut de Recherche pour le Developpement
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Cluster randomized - Step-wedged design

Eligibility

Sex/Gender
ALL
Age
6 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* global population

Exclusion criteria

* absence of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Difference of malaria incidence between control and intervention armsDay 0 (cross-sectional survey)Incidence will be calculated as the number of malaria cases detected during the cross-sectionnal surveys relative to the population size

Secondary

MeasureTime frameDescription
Difference of malaria prevalence between control and intervention armsDay 0 (cross-sectional survey)Prevalence will be calculated as the proportion of participants with malaria infection (i.e. positive blood smears) detected during the cross-sectionnal surveys

Countries

Burkina Faso, Côte d’Ivoire

Contacts

Primary ContactCédric Pennetier, PhD
cedric.pennetier@ird.fr0022656080455
Backup ContactFlorence Fournet, PhD
florence.fournet@ird.fr0033787232208

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026